药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dimethyltryptamine
Voxilaprevir
Glasdegib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dimethyltryptamine
Delamanid
Glasdegib may increase the QTc-prolonging activities of Delamanid.
Dimethyltryptamine
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Glasdegib.
Dimethyltryptamine
Mometasone furoate
The metabolism of Glasdegib can be decreased when combined with Mometasone furoate.
Dimethyltryptamine
Fluticasone
The metabolism of Glasdegib can be decreased when combined with Fluticasone.
Dimethyltryptamine
Trametinib
The metabolism of Glasdegib can be decreased when combined with Trametinib.
Dimethyltryptamine
Terodiline
The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Terodiline.
Dimethyltryptamine
Macimorelin
The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Macimorelin.
Dimethyltryptamine
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Deutetrabenazine.
Dimethyltryptamine
Ribociclib
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Glasdegib.
Dimethyltryptamine
Ivabradine
The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Glasdegib.
Dimethyltryptamine
Lumefantrine
The risk or severity of QTc prolongation can be increased when Lumefantrine is combined with Glasdegib.
Dimethyltryptamine
Artemether
The risk or severity of QTc prolongation can be increased when Artemether is combined with Glasdegib.
Dimethyltryptamine
Asenapine
The risk or severity of QTc prolongation can be increased when Asenapine is combined with Glasdegib.
Dimethyltryptamine
Iloperidone
The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Glasdegib.
Dimethyltryptamine
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Glasdegib.
Dimethyltryptamine
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Glasdegib.
Dimethyltryptamine
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Glasdegib.
Dimethyltryptamine
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Glasdegib.
Dimethyltryptamine
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Glasdegib.